Humanoid-universe.com

This is exactly the kind of context I was looking for. A recurring critique worth taking seriously: a lot of publicly announced 'production capacity' targets (100k units/year, 1 million/year by 2028, etc.) are aspirational manufacturing targets, not confirmed sales or deployment numbers, and the gap between the two has historically been large in hardware industries.

@green28 Short answer: Robotics-as-a-Service (RaaS) - subscription, leasing, or usage-based pricing instead of outright purchase - is emerging specifically to lower the adoption barrier for businesses that don't want to commit large capital expenditure to an unproven new category. Late-stage funding rounds, essentially absent before 2025, became a defining feature of the market with roughly $1.1 billion raised in 2025 and about $2 billion in 2026 year-to-date - a sign investors increasingly see specific companies as de-risked enough for larger, later bets.

@jessica_faro Thanks for laying this out, genuinely useful. Self-reported deployment and uptime numbers from humanoid companies are inherently hard to independently verify, since there's no standardized, third-party reporting requirement yet - a healthy dose of skepticism toward company press releases is reasonable until independent data catches up. Q1 2026 alone saw about $2.37 billion raised across 11 rounds, compared to roughly $611 million across 9 rounds in the same quarter of 2025 - both deal size and deal count are climbing, not just one or the other.

@joseph31 Respectfully, I think this undersells it a bit. Chinese humanoid startups reportedly accounted for around 65% of deal volume in 2025, while US companies still won the largest individual rounds, with at least three raises exceeding $400 million - deal count and deal size tell different stories depending on which region you're looking at.

Here's what I know on this: The humanoid robot market is estimated at roughly $5.41 billion in 2026, with projections reaching around $50 billion by 2035 (about 28% CAGR) - a genuinely huge projected growth curve, and also exactly the kind of number worth treating with healthy skepticism given how young and unproven the underlying revenue base still is. Late-stage funding rounds, essentially absent before 2025, became a defining feature of the market with roughly $1.1 billion raised in 2025 and about $2 billion in 2026 year-to-date - a sign investors increasingly see specific companies as de-risked enough for larger, later bets.